| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.32B | +48.5% |
| Cost of Revenue | $261.9M | -1.5% |
| Gross Profit | $1.05B | +69.8% |
| R&D Expense | $373.7M | -29.7% |
| SG&A Expense | $257.0M | -27.7% |
| Operating Income | -$345.4M | +69.5% |
| Interest Expense | $17.2M | -58.2% |
| Pre-tax Income | -$326.5M | +71.6% |
| Income Tax | $22.4M | +251.1% |
| Net Income | -$348.8M | +69.8% |
| EPS (Basic) | -$1.78 | +76.2% |
| EPS (Diluted) | -$1.78 | +76.2% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $380.2M | +104.0% |
| Accounts Receivable | $256.8M | +44.6% |
| Inventory | $5.7M | +35.7% |
| Current Assets | $2.22B | +106.3% |
| Total Assets | $2.77B | +94.4% |
| Current Liabilities | $1.31B | +38.3% |
| Total Liabilities | $3.29B | +66.2% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $282.9M | +486.6% |
| Capital Expenditures | $29.6M | +75.5% |
| Investing Cash Flow | -$830.1M | -116.5% |
| Financing Cash Flow | $736.5M | +85.0% |
| Free Cash Flow | $253.3M | +708.1% |
| -$519.6M |
| +6.2% |